ID   IMA7_HUMAN              Reviewed;         536 AA.
AC   O60684; B2RDC7; D3DPP5; Q5VVU3;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   15-MAR-2017, entry version 150.
DE   RecName: Full=Importin subunit alpha-7;
DE   AltName: Full=Karyopherin subunit alpha-6;
GN   Name=KPNA6; Synonyms=IPOA7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH KPNB1, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10523667; DOI=10.1128/MCB.19.11.7782;
RA   Koehler M., Speck C., Christiansen M., Bischoff F.R., Prehn S.,
RA   Haller H., Goerlich D., Hartmann E.;
RT   "Evidence for distinct substrate specificities of importin alpha
RT   family members in nuclear protein import.";
RL   Mol. Cell. Biol. 19:7782-7791(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-113, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Functions in nuclear protein import as an adapter
CC       protein for nuclear receptor KPNB1. Binds specifically and
CC       directly to substrates containing either a simple or bipartite NLS
CC       motif. Docking of the importin/substrate complex to the nuclear
CC       pore complex (NPC) is mediated by KPNB1 through binding to
CC       nucleoporin FxFG repeats and the complex is subsequently
CC       translocated through the pore by an energy requiring, Ran-
CC       dependent mechanism. At the nucleoplasmic side of the NPC, Ran
CC       binds to importin-beta and the three components separate and
CC       importin-alpha and -beta are re-exported from the nucleus to the
CC       cytoplasm where GTP hydrolysis releases Ran from importin. The
CC       directionality of nuclear import is thought to be conferred by an
CC       asymmetric distribution of the GTP- and GDP-bound forms of Ran
CC       between the cytoplasm and nucleus. {ECO:0000269|PubMed:10523667}.
CC   -!- SUBUNIT: Interacts with ZIC3 (By similarity). Forms a complex with
CC       importin subunit beta-1. {ECO:0000250,
CC       ECO:0000269|PubMed:10523667}.
CC   -!- INTERACTION:
CC       P01583:IL1A; NbExp=3; IntAct=EBI-359923, EBI-1749782;
CC       P46087:NOP2; NbExp=3; IntAct=EBI-359923, EBI-356811;
CC       P03466:NP (xeno); NbExp=5; IntAct=EBI-359923, EBI-2547640;
CC       Q9UKX7:NUP50; NbExp=5; IntAct=EBI-359923, EBI-2371082;
CC       Q15637:SF1; NbExp=4; IntAct=EBI-359923, EBI-744603;
CC       Q16594:TAF9; NbExp=3; IntAct=EBI-359923, EBI-712521;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:10523667}.
CC   -!- SIMILARITY: Belongs to the importin alpha family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF060543; AAC15233.1; -; mRNA.
DR   EMBL; AK315490; BAG37874.1; -; mRNA.
DR   EMBL; BT009843; AAP88845.1; -; mRNA.
DR   EMBL; AL445248; CAH71948.1; -; Genomic_DNA.
DR   EMBL; AL049795; CAH71948.1; JOINED; Genomic_DNA.
DR   EMBL; AL049795; CAI22056.1; -; Genomic_DNA.
DR   EMBL; AL445248; CAI22056.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX07567.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07568.1; -; Genomic_DNA.
DR   EMBL; BC020520; AAH20520.1; -; mRNA.
DR   CCDS; CCDS352.1; -.
DR   RefSeq; NP_036448.1; NM_012316.4.
DR   UniGene; Hs.470588; -.
DR   UniGene; Hs.711019; -.
DR   PDB; 4UAD; X-ray; 2.42 A; A=59-536.
DR   PDBsum; 4UAD; -.
DR   ProteinModelPortal; O60684; -.
DR   SMR; O60684; -.
DR   BioGrid; 117163; 71.
DR   DIP; DIP-27609N; -.
DR   IntAct; O60684; 56.
DR   MINT; MINT-1144956; -.
DR   STRING; 9606.ENSP00000362728; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   iPTMnet; O60684; -.
DR   PhosphoSitePlus; O60684; -.
DR   SwissPalm; O60684; -.
DR   BioMuta; KPNA6; -.
DR   EPD; O60684; -.
DR   MaxQB; O60684; -.
DR   PaxDb; O60684; -.
DR   PeptideAtlas; O60684; -.
DR   PRIDE; O60684; -.
DR   DNASU; 23633; -.
DR   Ensembl; ENST00000373625; ENSP00000362728; ENSG00000025800.
DR   GeneID; 23633; -.
DR   KEGG; hsa:23633; -.
DR   UCSC; uc001bug.4; human.
DR   CTD; 23633; -.
DR   DisGeNET; 23633; -.
DR   GeneCards; KPNA6; -.
DR   HGNC; HGNC:6399; KPNA6.
DR   HPA; HPA018863; -.
DR   MIM; 610563; gene.
DR   neXtProt; NX_O60684; -.
DR   OpenTargets; ENSG00000025800; -.
DR   PharmGKB; PA30190; -.
DR   eggNOG; KOG0166; Eukaryota.
DR   eggNOG; COG5064; LUCA.
DR   GeneTree; ENSGT00760000119094; -.
DR   HOVERGEN; HBG001846; -.
DR   InParanoid; O60684; -.
DR   OMA; HNDNKVA; -.
DR   OrthoDB; EOG091G095Z; -.
DR   PhylomeDB; O60684; -.
DR   TreeFam; TF354205; -.
DR   SignaLink; O60684; -.
DR   SIGNOR; O60684; -.
DR   ChiTaRS; KPNA6; human.
DR   GeneWiki; KPNA6; -.
DR   GenomeRNAi; 23633; -.
DR   PRO; PR:O60684; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000025800; -.
DR   CleanEx; HS_KPNA6; -.
DR   ExpressionAtlas; O60684; baseline and differential.
DR   Genevisible; O60684; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0008139; F:nuclear localization sequence binding; IBA:GO_Central.
DR   GO; GO:0008565; F:protein transporter activity; IBA:GO_Central.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR032413; Arm_3.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR002652; Importin-a_IBB.
DR   InterPro; IPR024931; Importing_su_alpha.
DR   Pfam; PF00514; Arm; 8.
DR   Pfam; PF16186; Arm_3; 1.
DR   Pfam; PF01749; IBB; 1.
DR   PIRSF; PIRSF005673; Importin_alpha; 1.
DR   SMART; SM00185; ARM; 8.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
DR   PROSITE; PS51214; IBB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Phosphoprotein;
KW   Protein transport; Reference proteome; Repeat; Transport.
FT   CHAIN         1    536       Importin subunit alpha-7.
FT                                /FTId=PRO_0000120729.
FT   DOMAIN        1     60       IBB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00561}.
FT   REPEAT       76    115       ARM 1; truncated.
FT   REPEAT      116    159       ARM 2.
FT   REPEAT      160    204       ARM 3.
FT   REPEAT      205    243       ARM 4.
FT   REPEAT      244    288       ARM 5.
FT   REPEAT      289    328       ARM 6.
FT   REPEAT      329    370       ARM 7.
FT   REPEAT      371    410       ARM 8.
FT   REPEAT      411    453       ARM 9.
FT   REPEAT      457    502       ARM 10; atypical.
FT   REGION      147    239       NLS binding site (major). {ECO:0000250}.
FT   REGION      316    404       NLS binding site (minor). {ECO:0000250}.
FT   MOTIF        45     54       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   HELIX        83     89       {ECO:0000244|PDB:4UAD}.
FT   HELIX        94    108       {ECO:0000244|PDB:4UAD}.
FT   STRAND      111    113       {ECO:0000244|PDB:4UAD}.
FT   HELIX       116    121       {ECO:0000244|PDB:4UAD}.
FT   HELIX       125    132       {ECO:0000244|PDB:4UAD}.
FT   HELIX       139    152       {ECO:0000244|PDB:4UAD}.
FT   HELIX       157    165       {ECO:0000244|PDB:4UAD}.
FT   HELIX       168    174       {ECO:0000244|PDB:4UAD}.
FT   HELIX       175    177       {ECO:0000244|PDB:4UAD}.
FT   HELIX       181    195       {ECO:0000244|PDB:4UAD}.
FT   HELIX       199    207       {ECO:0000244|PDB:4UAD}.
FT   HELIX       211    220       {ECO:0000244|PDB:4UAD}.
FT   HELIX       224    238       {ECO:0000244|PDB:4UAD}.
FT   HELIX       247    249       {ECO:0000244|PDB:4UAD}.
FT   HELIX       251    253       {ECO:0000244|PDB:4UAD}.
FT   HELIX       254    260       {ECO:0000244|PDB:4UAD}.
FT   HELIX       266    279       {ECO:0000244|PDB:4UAD}.
FT   STRAND      281    283       {ECO:0000244|PDB:4UAD}.
FT   HELIX       284    292       {ECO:0000244|PDB:4UAD}.
FT   HELIX       296    301       {ECO:0000244|PDB:4UAD}.
FT   HELIX       302    304       {ECO:0000244|PDB:4UAD}.
FT   HELIX       308    321       {ECO:0000244|PDB:4UAD}.
FT   HELIX       326    333       {ECO:0000244|PDB:4UAD}.
FT   TURN        334    336       {ECO:0000244|PDB:4UAD}.
FT   HELIX       338    344       {ECO:0000244|PDB:4UAD}.
FT   HELIX       350    363       {ECO:0000244|PDB:4UAD}.
FT   HELIX       368    376       {ECO:0000244|PDB:4UAD}.
FT   HELIX       380    389       {ECO:0000244|PDB:4UAD}.
FT   HELIX       392    408       {ECO:0000244|PDB:4UAD}.
FT   HELIX       411    419       {ECO:0000244|PDB:4UAD}.
FT   HELIX       423    427       {ECO:0000244|PDB:4UAD}.
FT   HELIX       428    431       {ECO:0000244|PDB:4UAD}.
FT   HELIX       435    455       {ECO:0000244|PDB:4UAD}.
FT   TURN        456    459       {ECO:0000244|PDB:4UAD}.
FT   HELIX       467    472       {ECO:0000244|PDB:4UAD}.
FT   HELIX       475    481       {ECO:0000244|PDB:4UAD}.
FT   HELIX       482    484       {ECO:0000244|PDB:4UAD}.
FT   HELIX       488    501       {ECO:0000244|PDB:4UAD}.
SQ   SEQUENCE   536 AA;  60030 MW;  9D0E27482B9BDED3 CRC64;
     METMASPGKD NYRMKSYKNN ALNPEEMRRR REEEGIQLRK QKREQQLFKR RNVELINEEA
     AMFDSLLMDS YVSSTTGESV ITREMVEMLF SDDSDLQLAT TQKFRKLLSK EPSPPIDEVI
     NTPRVVDRFV EFLKRNENCT LQFEAAWALT NIASGTSQQT KIVIEAGAVP IFIELLNSDF
     EDVQEQAVWA LGNIAGDSSV CRDYVLNCSI LNPLLTLLTK STRLTMTRNA VWALSNLCRG
     KNPPPEFAKV SPCLPVLSRL LFSSDSDLLA DACWALSYLS DGPNEKIQAV IDSGVCRRLV
     ELLMHNDYKV ASPALRAVGN IVTGDDIQTQ VILNCSALPC LLHLLSSPKE SIRKEACWTI
     SNITAGNRAQ IQAVIDANIF PVLIEILQKA EFRTRKEAAW AITNATSGGT PEQIRYLVSL
     GCIKPLCDLL TVMDSKIVQV ALNGLENILR LGEQEGKRSG SGVNPYCGLI EEAYGLDKIE
     FLQSHENQEI YQKAFDLIEH YFGVEDDDSS LAPQVDETQQ QFIFQQPEAP MEGFQL
//
